Company performance
Add to research
Current Price
as of Feb 06, 2025$0.21
P/E Ratio
N/A
Market Cap
$5.89M
Description
Add to research
T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. It offers T2Dx instrument, T2Bacteria, T2Candida, T2Biothreat panels, and T2MR technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
Metrics
Add to research
Overview
- HQLexington, MA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerTTOO
- Price$0.21-5.41%
Trading Information
- Market cap$5.89M
- Float44.49%
- Average Daily Volume (1m)1,335,673
- Average Daily Volume (3m)1,093,468
- EPS-$6.41
Company
- Revenue$7.68M
- Rev growth (1yr)34.85%
- Net income-$10.12M
- Gross margin-106.60%
- EBITDA margin-508.92%
- EBITDA-$10.10M
- EV$52.11M
- EV/Revenue6.79
- P/EN/A
- P/S0.49
- P/BN/A
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account